According to Pharma Mar's latest financial reports the company's current earnings are $0.18 Billion USD. , an increase over its 2023 earnings that were of -$1.35 Million USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | $15.29 M | -1234.98% |
2023 | -$1.35 Million | -102.94% |
2022 | $45.77 M | -61.69% |
2021 | $0.11 B | -28.89% |
2020 | $0.16 B | -944.25% |
2019 | -$19.91 Million | 10.16% |
2018 | -$18.07 Million | -13.68% |
2017 | -$20.94 Million | -0.61% |
2016 | -$21.06 Million | -267.24% |
2015 | $12.59 M | -55.95% |
2014 | $28.58 M | 13.21% |
2013 | $25.24 M | 71.43% |
2012 | $14.72 M | 2% |
2011 | $14.43 M | -213.08% |
2010 | -$12.77 Million | -72.22% |
2009 | -$45.97 Million | -15.35% |
2008 | -$54.31 Million |